Telix Announces Executive Leadership Appointments

MELBOURNE, Australia, Dec. 5, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces several key executive leadership appointments and promotions, reflecting the increased commercial focus of the Company and ongoing succession planning. Richard Valeix promoted to Group Chief Commercial Officer Richard Valeix, who has been in the role of Chief Executive Officer of Telix's...

Related Keywords

Monash ,South Australia ,Australia ,Japan ,United States ,New Zealand ,United Kingdom ,Belgium ,Melbourne ,Victoria ,Canada ,Switzerland ,Australian ,Kyahn Williamson ,Raphael Ortiz ,Richard Valeix ,Melanie Farris ,Christian Behrenbruch ,Genevieve Ryan ,Linkedin ,Monash University ,Telix Group ,Australian Securities Exchange ,Novartis ,Group Company ,Australian Pharmaceutical Industries Limited ,Orora Limited ,Telix Pharmaceuticals ,Drug Administration ,Governance Institute Of Australia ,Solicitor Of The Supreme Court ,Australian Therapeutic Goods Administration ,Prnewswire Telix Pharmaceuticals Limited ,Genevieve Ryan As Group Company ,Corporate Communications ,Health Canada ,Pharmaceuticals Limited ,Group Chief Commercial Officer ,Chief Executive Officer ,Europe Middle East ,Group Chief Commercial ,Advanced Accelerator Applications ,Chief Operating Officer ,Asia Pacific ,Company Secretary ,Group Company Secretary ,General Counsel ,Senior Legal Counsel ,Alternate Company Secretary ,Compliance Officer Australia ,Graduate Diploma ,Applied Corporate Governance ,Governance Institute ,Supreme Court ,Senior Vice President Global Governance ,Managing Director ,Telix Pharmaceuticals Limited ,